Structural DNA nanotechnology utilizes synthetic or biologic DNA as designer molecules for the self-assembly of artificial nanostructures. The field is founded upon the specific interactions between DNA molecules, known as Watson-Crick base pairing. After decades of active pursuit, DNA has demonstrated unprecedented versatility in constructing artificial nanostructures with significant complexity and programmability. The nanostructures could be either static, with well-controlled physicochemical properties, or dynamic, with the ability to reconfigure upon external stimuli. Researchers have devoted considerable effort to exploring the usability of DNA nanostructures in biomedical research. We review the basic design methods for fabricating both static and dynamic DNA nanostructures, along with their biomedical applications in fields such as biosensing, bioimaging, and drug delivery.
INTRODUCTION
DNA (deoxyribonucleic acid) is the genetic information carrier for all known living organisms and some viruses. It is a biopolymer of nucleotides, with each nucleotide containing one of four nucleobases, cytosine (C), guanine (G), adenine (A), or thymine (T); a deoxyribose; and a phosphate group. The interaction between two DNA biopolymers or strands is determined by the coding of bases, known as Watson-Crick base pairing (1) , where A pairs with T and C pairs with G through hydrogen bonding. Massive amounts of information, genetic or nongenetic (2) , can be stored in a long piece of DNA with defined sequences.
From a material perspective, the unique characteristics of DNA make it a promising and versatile material candidate for a wide range of applications. For instance, the DNA double helix (e.g., B-form) has a diameter of 2 nm and a helical turn of 10.5 bp (or 3.4 nm). More importantly, the interactions between DNA molecules are specifically governed by Watson-Crick base pairing. Such specificity has led to the programmability of DNA interactions and the foundation of structural DNA nanotechnology. Structural DNA nanotechnology is the field in which DNA (or RNA) molecules are utilized as building blocks for self-assembly into artificial nanostructures. Its conceptual foundation can be traced to 1982, when Seeman (3) proposed utilizing DNA structures to aid the crystallization of proteins. Three decades of development have led to the use of DNA as a designer molecule with an enormous capacity to construct both static and dynamic nanostructures with unprecedented precision and complexity. These DNA nanostructures are a set of materials with unique properties (e.g., well-defined size, geometry, interactions) that can be utilized on their own or be combined with other materials for many biomedical applications. For example, pristine DNA nanostructures have been used to interact with biological systems to enable biosensing (4), bioimaging (5), or drug delivery (6) . In this review, we describe the basic design principles and representative examples of both static and dynamic DNA nanostructures. We also present a comprehensive review of the biomedical applications of such DNA nanostructures.
Static DNA Nanostructures
DNA tiles are a set of artificial structures composed of several DNA single strands with unique sequences, whose hierarchical assembly leads to the formation of large DNA structures. Seeman et al. (7) reported the first DNA tile, named the immobile four-way junction, that was built from four single DNA strands (Figure 1a) . This DNA tile closely resembles the natural Holliday junction, in which strand migration is prevented by minimizing the sequence symmetry in the junction. Three-, five-, six-, eight-, and 12-way junctions have been constructed via the same strategy (8) (9) (10) . Nevertheless, such DNA tiles failed to assemble into higher-order structures due to significant structural flexibility both on and off the tile plane. Rigid DNA double-crossover (DX) structures were then proposed and fabricated (11) . In these structures, two four-way junctions are confined within two parallel DNA double helices by two crossovers (Figure 1b) . In 1998, a twodimensional (2D) DNA crystal structure was fabricated through sticky-end mediated assembly of a two-arm DX tile (Figure 1c ) (12) . This was the first example of a higher-order crystal-like structure assembled from DNA, representing a milestone in the field of structural DNA nanotechnology.
Subsequently, DNA 2D crystals containing diverse and complex patterns were assembled from three-arm (14) , four-arm (13, 27) , five-arm (17) , or six-arm (15) DNA tiles (Figure 1d ). Combining the assembly of multiple DNA tile designs with a variable number of arms resulted in 2D crystals of much higher complexity, such as Archimedean crystals (28, 29) . The field has long pursued three-dimensional (3D) DNA crystals, beginning with a DNA tensegrity triangle tile created in 2009 (Figure 1d ) (18) . In addition to infinite-size crystal structures, 3D polyhedral structures (Figure 1d ,vi) can be constructed from DNA tiles (16, 17, 21, (23) (24) (25) (26) . These DNA tile designs typically produce highly periodic and symmetric structures and thus are unable to construct arbitrary structures with well-defined size, shape, and pattern. In a complement to conventional DNA tile designs, Yin and colleagues (19, 20) developed a special type of DNA tile referred to as a single-stranded DNA (ssDNA) tile (SST), later referred to as a DNA brick. In DNA brick design, each ssDNA has a unique sequence and acts as a molecular brick to intact with other bricks, forming the designed 2D (Figure 1e,i) (20) or 3D (Figure 1e ,ii) (19) object. A unique advantage of DNA brick design is its modularity. In other words, a master set of DNA strands can serve as a 2D or 3D canvas, enabling the construction of a large number of arbitrary DNA objects simply by excluding designated strands. This method enables one to build a library of DNA objects with arbitrary sizes and shapes in a high-throughput fashion. Similar to conventional DNA tiles, DNA bricks can be induced to form infinite-size crystal structures by bridging the head and tail bricks (Figure 1d,iii) (22) .
Origami refers to the art of folding and sculpting flat paper into objects with arbitrary shapes. DNA origami, reported by Rothemund (30) in 2006, creates similar art at the nanoscale. In the molecular self-folding process, a long ssDNA (scaffold DNA), typically the M13 bacteriophage genome DNA (∼7,000 nt), is folded into designed objects with well-defined geometry by hundreds of synthetic, short (20-60 nt) ssDNAs (known as staple DNAs). Note that, prior to the DNA origami era, a few studies demonstrated similar concepts. For instance, in 2003, Yan et al. (31) ligated ssDNAs into longer molecules to serve as scaffolds to direct the nucleation of DNA tiles forming discrete objects or lattice structures with bar-code patterns (Figure 2a) . A year later, Shih et al. (32) folded a 1,669-nt-long ssDNA molecule into a 3D octahedron with five 40-nt-long synthetic DNA molecules (Figure 2a) . Nonetheless, these two studies did not demonstrate the versatility of this technique for the construction of DNA objects with complex and arbitrary geometries.
The use of commercially available ssDNA (M13 DNA) as a scaffold is another unique benefit introduced by Rothemund. Two distinct DNA origami design strategies have been developed so far: lattice-based origami and wire-frame origami (Figure 2b-d) . These methods differ in the arrangement of helices within the DNA origami objects. Earlier DNA origami studies built upon the lattice-like packing of DNA helices, in which the helices were closely packed into square (30, 33) , honeycomb (34) , hexagonal (35) , or hybrid lattices (35) . Flat 2D objects, such as the famous smiley face (Figure 2c,i) , were the first to be constructed (30) . Further folding of flat 2D origami sheets led to the formation of hollow 3D containers, such as a DNA box (Figure 2c ,ii) (36) and a tetrahedron (37) . In contrast to the folding of 2D flat sheets, the interhelical angles and length of adjacent DNA helices were arranged into concentric rings that can be rationally designed to induce curvature in 3D space and thus form hollow 3D objects with complex shapes (38) . Solid 3D DNA origami objects can be assembled via close-packing DNA helices into lattices in 3D space (Figure 2c ) (33) (34) (35) . Curvature can be introduced into solid objects via rationally adding or deleting bases between crossovers (39). In contrast to lattice-based DNA origami, wire-frame DNA origami produces porous structures by minimizing the packing of DNA helices. For instance, Yan and colleagues (40) used DNA four-arm junctions as vertices of a DNA network to fabricate DNA gridiron structures (Figure 2d ). Multiarm junctions (49) were then used to construct wire-frame DNA origami structures with greater complexity (Figure 2d ). Bathe and colleagues (51) developed an algorithm named DAEDALUS that enabled the automated design of a large library of polyhedral structures (Figure 2d ). Högberg and colleagues (47) reported an alternative wire-frame strategy that renders designed objects into meshes. 3D objects, such as the Stanford bunny (Figure 2d) , have been fabricated through this method. Wire-frame DNA origami excels at constructing arbitrary-shaped, soft, and porous structures. The loose arrangement of the DNA helices means that wire-frame DNA origami structures have high resistance against cation (e.g., Mg 2+ , Na + ) depletion, as cations are needed to shield the natural negative charge of DNA helices in order to realize close packing (47, 51) . Therefore, wire-frame structures have greater potential for intracellular applications because physiological fluids have a relatively low abundance of cations.
Both scaffold and staple DNA can be engineered to build larger DNA origami structures. Fan and colleagues (44) utilized polymerase chain reaction to produce a 26,182-nt-long scaffold DNA molecule (Figure 2e ). LaBean and colleagues (46) constructed a M13-λ hybrid phage to produce a 51,466-nt-long scaffold DNA molecule that yielded origami structures that were seven times as massive as ordinary M13-based structures (Figure 2e) . Structures preassembled from DNA tiles (41) or DNA origami (43) can serve as superstaples to fold the M13 scaffold into much larger structures (Figure 2e ). An alternative route is the hierarchical assembly of DNA origami tiles, which can be realized through sticky-end cohesion or blunt-end stacking. For instance, symmetric polyhedral structures have been assembled from DNA origami tripod (Figure 2f ) (45); a nanoman was assembled from many units of a DNA origami square (Figure 2f ) (50) . Micrometer-scale DNA origami lattices containing hundreds of DNA origami tiles can also be created (Figure 2f ), either in solution (42, 48, 52) or on a substrate (53) (54) (55) (56) .
Many software programs and algorithms exist to facilitate the design of complex DNA structures. For instance, Tiamat is employed for the design of DNA tiles and simple DNA origami structures. NanoBricks is used for the design of DNA brick structures. caDNAno (57) excels at designing lattice-based DNA origami structures. DAEDALUS (51) works within MATLAB and Python to design wire-frame DNA origami structures. Detailed information about the design process can be found in the references provided.
Dynamic DNA Nanostructures
The ability to design precise complex geometry at the molecular scale renders structural DNA nanotechnology capable of constructing nanomaterials, devices, and machinery that can sense, respond to, and navigate the local environment; transfer motion, forces, and energy; and process and communicate information. Constructing dynamic DNA-based devices with these functions generally requires integrating various underlying components with a range of mechanical and chemical properties, including flexibility and biochemical addressability. In general, several types of dynamic features such as constrained thermal fluctuation for diffusive search processes, programmed machine-like planer (2D) or spatial (3D) motion, precise conformational changes, and tunable distribution of states, can be designed into devices by use of mechanical design features. The components for mechanical design can be broken down into combinations of flexible elements (e.g., ssDNAs), compliant or deformable elements [double-stranded DNAs (dsDNAs) or bundles of only a few dsDNAs], and stiff elements (e.g., bundles of dsDNAs with many helices in the cross section) (58) . At length scales shorter than 50 nm, the persistence length of dsDNA (59, 60) , individual dsDNA helices can also function as stiff components. Typically, local motions are facilitated by the flexible elements, or deformation can be distributed over compliant elements. These local or distributed motions can be translated into larger motions or conformational changes by stiff elements. Integrating these components enables the design of dynamic DNA nanodevices with a range of functions. In general, dynamic DNA nanodevices can be classified into DNA motors (walkers and rollers), reconfigurable strand systems, systems with local reconfiguration of strands or subunits within larger templates, triggered containers, mechanical joints, and multijoint mechanisms ( Figure 3) .
DNA motors, recently reviewed by Pan et al. (61), undergo processive motion by moving along successive binding sites organized along a track. Binding to the track is achieved by basepairing interactions between ssDNAs on the device and complementary ssDNAs on the track. To achieve processive motion, the device must remain bound to the track by at least one binding site during successive steps. DNA walkers often contain two track-binding ssDNAs (62-67) so that one can remain anchored while the other steps to a neighboring binding site via a diffusive search between the two complementary strands. Once both strands are anchored to the track, the motion proceeds by biasing a step toward the leading strand that occurs via mechanisms to release the lagging binding site, such as strand displacement (62) (63) (64) (65) (66) (67) . Alternatively, walking can be driven enzymatically through the use of enzymes that nick the track strand when it is hybridized to the walker strand (68, 69) . The track strand leaves a toehold region so that a neighboring track strand can displace the prior anchoring site. This approach is referred to as the burned-bridges approach because the walker can proceed only in the direction of undigested track strands. Rollers proceed along tracks via similar mechanisms, but engagement of successive binding sites along the track occurs through the rolling motion of a rigid particle (71, 72, 90) .
Track substrates include DNA (62-65, 67, 69, 71, 90-92) , carbon nanotubes (70, 93) , glass or gold-coated surfaces (72) , and microparticles (66, 94, 95) . Figure 3a illustrates DNA motors that traverse tracks consisting of a microparticle surface (66), a carbon nanotube (70), a DNA origami platform (71) , and a gold-coated glass surface (72) . In the case of DNA-based tracks, binding sites can be placed at regular intervals according to the helical pitch of dsDNA (10.5 bp or 3.5 nm) along a single-helix track, or at varied spacing along adjacent helices in DNA origami nanostructures. Recent advances in imaging of DNA walkers have led to improved quantification of motion and steps, including successful visualization of individual steps of walkers stepping on DNA origami tracks where binding sites are positioned ∼6 nm apart (96, 97) . Although the conceptual design of DNA walkers was inspired by natural biomolecular motors and the step sizes can be similar to, for example, kinesin, which takes 8-nm steps (98) , their speeds are much slower. Typical speeds of nanoscale DNA motors range from ∼1 to 10 nm/min (70, 92, 96, 99) , whereas kinesin motors can move along microtubules at speeds of ∼50 µm/min. (74) or (iii ) DNA-binding proteins (75) , or (iv) changes in pH (76) . These strand systems are often used as sensors such that shape changes lead to measurable readouts. (c) Strand-based devices can be mounted onto the structure or material platforms (i ) to enhance strand interactions for molecular computation (77), (ii ) to transport molecular cargo along a structure template (78) , (iii ) to reconfigure patterns in a template (79) , or (iv) to communicate information by cascaded conformational changes (80 ∼1-5 µm/min (72). Significant research efforts are pursuing improvements in speed and control, broad integration with other materials and structures, and enhancement and application of motor function. Reconfigurable strand systems (Figure 3b ) are similar in size to typical DNA walkers, with dimensions on the ∼1-10-nm scale, but are designed to undergo conformational changes in response to specific triggers such as DNA strand displacement (73), site-specific binding of biomolecules (74, 75) , or changes in solution conditions such as pH (4, 76) . This responsive function makes these strand-based devices powerful tools for sensing various biomolecules or environmental conditions. These devices have even been implemented in living cells to probe pH (4, 76) or detect ion concentrations (100), and they have been in full organisms, such as Caenorhabditis elegans, to measure local pH (101) . In addition, these devices can be functionalized with, for example, targeting moieties (76, 101, 102) or other aptamers that enable detection of specific molecular targets (103) .
These reconfigurable strand elements can be mounted onto larger nanostructures or material templates (Figure 3c ) to provide local actuation, sensing, or communication elements or to enhance control or performance of the device function. For example, a recent study demonstrated a platform in which computations can be carried out via interactions between strands immobilized on a DNA origami nanostructure platform; localizing interacting strands on a static platform reduces the time for computation steps from hours to minutes compared with similar processes carried out in solution (77) . Simmel and colleagues (78) used reconfigurable strands to transport cargo on a DNA origami platform (Figure 3c,ii) . The ability to reconfigure strands in a larger template can also add functionality to the template, such as changing local structure patterns (Figure 3c,iii) (79) or reconfiguring structures through the selective removal of entire layers (104) . More recently, Song et al. (80) developed an approach to transmit information along DNA nanostructure via propagation of local conformational changes of structural units (Figure 3c,iv) . These controllable strand modules have recently been implemented within DNA crystals (105) , suggesting that these devices can impart local function to macroscopic (∼100-µm) material systems.
The ability to design complex geometry, in combination with reconfigurable and biochemically addressable components, offers the potential for drug delivery devices that can encapsulate Figure 3d ,i depicts a smaller (∼20-nm) box that can be repeatedly opened and closed through successive strand displacement steps (81) . Other studies have exploited the biochemical specificity of DNA-based aptamers to create containers responsive to non-DNA triggers, such as small molecules involved in bacterial cell signaling (Figure 3d ,ii) (82) or cell surface receptors (Figure 3d,iii) (6) . In addition to responding to specific target molecules, a recent study demonstrated the ability to open a spherical DNA origami capsule by light actuation (Figure 3d,iv) (83) . Given recent advances in studies of the behavior of DNA nanostructures in vivo, including investigations showing effective stability and distribution (107, 108) as well as promising targeting (109) and tumor efficacy (110) in mice, this line of research is likely to be extended in the coming years with increasing emphasis on translational studies. An emerging area of DNA nanotechnology involves the development of dynamic DNA origami nanodevices that exhibit well-defined mechanical motions, much like macroscopic machines and robots. These devices typically integrate multiple stiff bundle components whose relative motion is enabled by flexible ssDNA domains. These ssDNA connections can enable angular motion via pinlike connections between dsDNA bundle components (Figure 3e,i) (84) or multiple short ssDNA connections arranged along a line to enable hinging motion around a defined axis of rotation (Figure 3e,ii) (85, 111) . As an alternative approach, relative motions of components can be achieved using close-fitting complementary geometries such as a rotor inside a stator (Figure 3e,iii) (86) . This approach of combining components with complementary geometries to constrain relative motion has also been used to enable piston-like linear motion via relative sliding of a tube along a track (Figure 3e,iv) (87, 112) .
These mechanical joints with specific types of motion can be integrated into multijoint mechanisms capable of more complex mechanical motion and function. For example, integration of four-bundle components with four hinge joints into a closed loop enables the construction of fourbar linkages that exhibit well-defined planar motions (Figure 3f,i) (88) . A recent study reported the construction of arrays of similar mechanisms to achieve shape-transforming 2D materials (113) . More complex 3D transformations can be achieved by changing the orientations of angular degrees of freedom, as demonstrated by DNA origami Bennett linkage (Figure 3f,ii) (87) . Marras et al. (87) demonstrated the integration of angular and linear motion in a DNA origami crankslider mechanism (Figure 3f,iii) that couples translation of a slider component to hinge rotation, similar to crank-slider mechanisms that couple linear motion of a piston to rotation of a wheel in classic steam-locomotive trains.
Although the majority of machines utilize rigid components with highly flexible joints, the integration of deformable, or compliant, components (114) [i.e., compliant mechanism design (115)] has become a powerful approach in macroscopic mechanical design, offering advantages such as tunable mechanical properties, improved motion stability, and complex mechanical behavior such as bistability. Similarly, the integration of compliant components into DNA origami nanostructures has led to distributed deformation (116) , tunable mechanical properties (114, 117) , and programmable bistable behavior (Figure 3f,iv) (89) .
Exploiting these dynamic devices, in particular for nanorobotic systems, requires the ability to control their conformation. The mostly widely used approach to control dynamic nanodevices is via binding or displacement of DNA strand components, initially developed by Yurke et al. (118) . The diversity and specificity of DNA sequences make this a highly versatile approach that can be used to achieve processive motion (Figure 4a,i) 
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Actuation mechanisms for dynamic DNA nanodevices. (a) The most common approach to actuate DNA nanodevices is DNA binding or strand displacement to facilitate or release connections between components of the system, respectively. This approach enables (i ) processive motion of DNA motors (A-1 through A-4 denote anchoring sites of the DNA motor) (90), (ii ) opening and closing of hinge-like devices (119), or (iii ) extension and retraction of a sliding joint (112) . (b) To avoid the need to introduce DNA actuator strands, devices can be designed to be responsive to local solution conditions such as (i ) pH to trigger formation of a triplex from a duplex and single-stranded DNA (ssDNA) (120) or (ii ) temperature and ion concentrations to mediate local interactions that stabilize a closed state (113) . These approaches generally enable faster, repeatable, and potentially less invasive control mechanisms. (c) Other mechanisms for controlling DNA nanodevices include (i ) photoactivation, for example, to reversibly control assembly of multiple structures (SS indicates a disulfide bond that connects the photoswitchable overhang strand to the structure) (121) , and (ii ) molecular crowding, which can bias a dynamic device into a compacted state (122) . Abbreviations: G6pDH, glucose-6-phosphate dehydrogenase; PEG, poly(ethylene glycol); NAD + , nicotinamide adenine dinucleotide; ssDNA, single-stranded DNA.
motors, strand reconfiguration (73, 118) , angular motion (Figure 4a ,ii) (119), linear motion (Figure 4a,iii) (112) , and container opening and closing (81, 106) . Because it is easy to incorporate ssDNA strands at specific locations on DNA nanostructures, nearly any dynamic DNA device can be actuated via DNA strand binding and/or displacement (123) . However, limitations, especially the relatively slow response times (minutes or greater) (124) (Figure 4b ,ii) (113), both of which offer response times on the ∼10-s scale. Temperature has the advantage of being easily adjusted without the need to change the solution environment, which means that it is straightforward to reverse and repeat the actuation via cyclic temperature changes. Gerling et al. (113) illustrated actuation via temperature changes over ∼1,000 cycles. Similarly, light-mediated actuation can be used as an external input to reconfigure devices (125) , control the position of a rotor (126) , actuate DNA walkers (97), or control assembly and disassembly (Figure 4b,i) (121) . Most of these photoactuated devices incorporated azobenzene units along latching strands, where UV-driven trans-to-cis conformation change destabilizes hybridized strands (127) , although some studies have incorporated photocleavable molecules (83) . Another recent study demonstrated that dynamic closing of a device can be driven by molecular crowding (Figure 4c ,ii) (122) . Although this approach requires changing the solution conditions, it may give rise to devices that can respond to changing environments in biological systems, such as inside cells. Additionally, recent research has demonstrated a nanodevice that can reconfigure upon interaction with a lipid bilayer (128) , which may enable the construction of DNA devices that interact with biological membranes. Various stimulus response mechanisms have been developed, but major challenges in controlling dynamic nanodevices remain. Although methods including temperature-and pH-mediated actuation have led to faster response times, down to ∼10 s, these response times are still much slower than inherent fluctuation times, suggesting that DNA devices could be reconfigured with significantly faster methods. In addition, existing control methods simply trigger the structure between a freely fluctuating state and a single, preprogrammed, closed or latched state. The ability to achieve continuous control over a wide range of conformations remains a challenge. Lastly, the effects of force on actuation have not been studied; such investigations are necessary in order to consider the possibility of force-generating DNA actuators and motors. Because many processes rely on random thermal fluctuations, more advanced methods may be required to overcome or generate any significant forces.
The use of biological molecular motors may present solutions to some of these challenges or enable new applications for DNA devices. Although at present it is difficult to achieve function similar to that of natural motors, particularly in terms of kinetic rates and chemical fuel sources, one can draw interesting and useful analogies by comparison. In some cases, such as in DNA walkers, designs are directly inspired by molecular motors such as myosin ( Figure 5 ) (63, 129) . Some functional features, such as coordination between track-binding domains, have already been explored (64, 65) , and other features, such as mechanical communication between motorheads (130) or long linkers between motor body and the motorheads (i.e., binding domain), could provide useful design inspiration. Freely rotating DNA devices (86) undergo similar motions to biological rotary motors such as F1-ATPase (Figure 5 b) (131) , but they are limited in terms of directional rotation and rotation speeds; similarly, sliders that can travel relatively long distances along DNA origami tracks (132) are similar in geometric and motion design to DNA translocating motors such the bacteriophage T4 portal protein (Figure 5 b) (133) . Lastly, DNA origami hinges can be similar in size and shape to proteins like condensins or cohesins (134) , which regulate chromatin structure, or the monopolin complex (Figure 5 b) (135) , which regulates attachments between kinetochores and microtubules in fungi. Given recent uses of DNA origami nanodevices to engage and study nucleosomes (136, 137) , dynamic nanodevices could find application in regulating the structure of chromatin or other large biomolecular complexes and materials. (133), which could serve as inspiration for new mechanisms to achieve relative motion of tight-fitting components. (iv) DNA origami hinges (87) are similar in size scale and motion characteristics to proteins such as (viii ) the monopolin complex (135) that regulate chromatin interactions or structure. These protein complexes may provide useful concepts with which to develop DNA nanodevices that control the structure of chromatin or other large macromolecular complexes.
BIOMEDICAL APPLICATIONS OF DNA NANOSTRUCTURES
As discussed above, complex static and dynamic nanostructures of arbitrary geometries may be constructed via DNA self-assembly. These DNA nanostructures have been explored for diverse biological and biomedical applications for several reasons. First, because the nanostructures are made from DNA, they are intrinsically biocompatible. Second, DNA structures, especially origami, can be utilized as nanoscale breadboards because they exhibit extremely high addressability. Roughly 200 staple oligonucleotides work cooperatively with a long-chain scaffold strand, forming an origami structure. The staple strands may be used for grafting and organizing biomolecules including nucleic acids, proteins, and nanoparticles. Third, individual DNA strands within DNA nanostructures may be further modified chemically if necessary. For example, there is a plethora of organic fluorophores and photoresponsive moieties (such as azobenzene) that may be functionalized in DNA strands. Such functionality and chemical versatility make DNA ideal for use in diverse applications. Given these unique advantages, DNA nanostructures have been explored for (a) biomolecular sensing, (b) both in vitro and in vivo imaging, and (c) drug delivery applications. In this section, we discuss how DNA nanostructures can be used in such applications. As several in-depth reviews on each of these applications are available elsewhere (e.g., 138), this overview highlights how static and dynamic DNA nanostructures are exploited distinctly. We focus on the unique aspects of self-assembly and programmability that enable static and dynamic structures for the applications. We do not discuss studies of DNA computations inside cells (139) or biomolecular sensors based on simple DNA-based molecular beacons (140, 141) and origami-based nanopores (142) . 
Biomolecular Sensing: Optical Detection and Atomic Force Microscopy Measurements
Biomolecular sensors are composed of target recognition elements and signal transducers integrated into DNA nanostructures. Dynamic DNA structures reconfigure their conformations in response to analyte recognition, where shape-changing events are used as signal readouts, often with atomic force microscopy (AFM). In contrast, static structures are used as platforms where target binding events are recorded via direct AFM measurements of target molecules or indirect remote measurements using, for instance, fluorescence resonance energy transfer (FRET)-based optical detection. The recognition elements typically rely on target-ligand binding interactions. The ligands are often nucleic acids, aptamers, and antibody proteins. Figure 6 shows examples of biomolecular sensing using static DNA nanostructures. Endo & Sugiyama (143) constructed origami rectangles with square holes at the center and two DNA cantilevers bridged across the holes (Figure 6 a) . They used this platform in a series of studies to investigate the dynamic motions and kinetics of biomolecular analytes at the single-molecule level with high-speed AFM. For example, DNA binding events such as DNA base pairing, guanine quadruplex formation, and DNA-enzyme binding resulted in association or dissociation of the cantilever bridges (e.g., Holliday junctions) that was detected by AFM. Similar schemes were used to detect B-Z transitions of DNA strands as a function of Mg 2+ concentration and to demonstrate photoregulated DNA base pairing using photoisomerizable azobenzene moieties.
The programmability and addressability of DNA origami structures have been demonstrated for a label-free hybridization assay (Figure 6 b) . Yan and colleagues (144) constructed an origami rectangle containing three different probes arranged in a spatially resolved fashion. The capture of target RNA strands by the probes stiffened the probes, which could then be detected by AFM. This study exemplifies the simple yet powerful approach of DNA nanostructures, leading to the development of other DNA assembly-based biosensors.
In dynamic biosensor schemes, structural reconfigurations are associated with analyte binding events (Figure 7 ) . A popular sensor design is a scissor/plier-type structure, which was demonstrated independently by multiple groups. Kuzuya et al. (145) first created single-molecule beacons from DNA origami that pinch closed upon binding to a target molecule (Figure 7 a) . They also demonstrated unzipping by target binding. This design enabled examination of various analytes, including streptavidin, immunoglobulin G, telomere strands, microRNA (miRNA), and ATP. The structural changes were detected by AFM and fluorescence measurements. A similar structural design was adopted by Niemeyer and colleagues (146) , who investigated analyte binding kinetics (Figure 7 b) .
The Yan group (147) expanded this concept to construct a DNA tweezer that pinches near a fuel strand, initiating a NAD + /NADH reaction by glucose-6-phosphate dehydrogenase (Figure 7 c) . The reconfiguration dynamics were characterized by recording fluorescence signals from a by-product molecule and a FRET pair. Figure 7 d shows a nanomechanical origami device capable of long-range allosteric activation, proposed by Ke et al. (88) . Four rigid rods are connected by flexible single-stranded hinges, allowing reconfiguration of the entire structure via allosteric changes upon recognition of analyte molecules. Such dynamic nanodevices should become useful in biosensing and single-molecule biophysics studies.
Cellular Imaging
Cellular imaging with DNA probes and DNA imaging inside cells are routinely performed in biological and biomedical research. DNA strands are typically tagged or modified with radioactive or fluorescent moieties for imaging. In particular, optical imaging with fluorophore-tagged DNA strands is one of the most common methods for cellular imaging, and it is possible to achieve spatial resolution far below the fundamental diffraction limit (∼λ/2)-so-called superresolution microscopy. Notably, DNA nanotechnology offers unique advantages with unprecedented predictability and programmability that allow us to move beyond current microscopy techniques. For example, one of the most critical limitations in stochastic subdiffraction imaging is the availability of photoswitchable fluorophores with desirable spectroscopic characteristics. To address this issue, Jungmann et al. (148, 149) employed a simple yet powerful technique involving a new type of superresolution fluorescence microscopy that uses transient binding of regular fluorophore-tagged oligonucleotides onto DNA origami structures for localization. Diffusing imager strands bind transiently and repetitively to the complementary docking strands on the origami, thus switching continuously between on and off states (Figure 8 a) . In this DNA-based point accumulation for imaging in nanoscale topography (DNA-PAINT) scheme, photobleaching can be overcome. The authors extended this approach by integrating antibodies to the docking strands so that different parts of cells could be imaged with a single type of fluorophore. Here, one set of imager strands was first imaged and washed, then exchanged with another set for another run of imaging that could be repeated for different cellular components (a technique known as Exchange-PAINT) to achieve multiplexed imaging (Figure 8 b) . The authors successfully demonstrated this concept in fixed cells (Figure 8 c) and reported sub-10-nm spatial resolution. The Krishnan group (150) proposed another novel technique for cellular imaging by integrating the programmability of DNA nanostructures and the photostability of nanocrystal quantum dots (QDs) that have superior photoproperties compared with those of conventional fluorescent proteins and organic dyes. These authors encapsulated a QD inside DNA icosahedra for single-particle tracking (SPT) to investigate endocytosis (Figure 8 d) . Endocytic ligands were attached to the DNA icosahedra, and the individual particles were imaged during the cellular uptake process used to study endocytic pathways. In addition to performing SPT studies with DNA nanocages, the Krishnan group (4, 150) has proposed the use of dynamic, reconfigurable DNA structures for cellular imaging (Figure 9 ). These DNA nanostructures are responsive to the change of pH in the local environment, reconfiguring their conformations to open at high pH and close at low pH. This pH-responsive behavior can be exploited in conjunction with FRET for spatiotemporal mapping of cellular components in 
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Figure 9
Dynamic DNA nanostructures for cellular imaging proposed by the Krishnan group (4, 150) . (a,b) The structures reconfigure their conformations in response to a change of pH in the local environment, which is used to image (c) cell components and (d ) endocytic processes in living organisms. Three oligonucleotides are labeled O1, O2, and O3, where O1 and O2 are hybridized to flanking sequences on O3. Abbreviations: EE, early endosome; LE, late endosome; LY, lysosome; SV, spherical vesicle.
organisms (Drosophila and C. elegans). The authors further developed this concept by integrating two pH-responsive DNA nanomachines to visualize and study distinct endocytic pathways (101).
Drug Delivery and Therapeutics
Drug delivery and therapeutics represent one of the most promising applications of structural DNA nanotechnology. Several studies have proposed various structures and strategies to load, deliver, and release molecular drugs for cancer treatment, gene silencing, immunostimulation, and photodynamic therapy. The general schemes proposed in these studies involve the use of DNA nanostructures loaded with disease/function-specific agents and ligands to locate the target location, followed by the release of the agents from the structures to complete the intended tasks. As described above, the proposed DNA assemblies may be classified into static and dynamic structures.
The most common use of static DNA structures in therapeutics is anticancer drug delivery. In 2012, the Ding group (151) and the Högberg group (152) independently constructed DNA origami structures incorporating the anticancer drug doxorubicin (DOX) via intercalation (Figure  10 a) . The drug-loaded DNA structures were incubated with and internalized by human breast cancer cells, which clearly demonstrated apoptotic behavior. Both groups demonstrated efficient drug delivery and the efficacy of the anticancer treatment as a function of dosage. In a later study, Ding and collaborators (153) examined origami-based anticancer drug carriers in small animals (Figure 10 b) . The origami structures were decorated with QDs whose fluorescence properties were used to investigate biodistribution and pharmacokinetics. The DOX was demonstrated to be effective in vivo and had no measurable cytotoxic effects.
DNA structures have been explored for biomedical applications in addition to cancer therapy. The Liedl group (154) examined the feasibility of DNA structures for immunostimulant delivery to immune cells (Figure 10 c) . They prepared DNA nanotubes containing CpG sequences and examined their effects in spleen cells. Their findings show that the carriers have no significant toxicity and that their immunological behavior functioned as designed (154) . In another study, Langer and colleagues (109) used tetrahedral DNA oligonucleotide nanoparticles (ONPs) as vehicles for small-interfering RNA delivery (Figure 10 d) . They successfully demonstrated silencing of target genes in small animal models. 
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Figure 10
Static DNA nanostructures for drug delivery and therapeutics. (a) Anticancer drug DOX-loaded DNA origami for human cancer treatment (152) . (b) Self-assembled DNA triangles for in vivo cancer therapy (151) . (c) Delivery of immunostimulants (154) . (d ) DNA tetrapod for small interfering RNA (siRNA) delivery in vivo (109) . Abbreviations: CD69, cluster of differentiation 69; CpG, cytosine-phosphate-guanine; DOX, doxorubicin; EPR effect, enhanced permeability and retention effect; ONP, oligonucleotide nanoparticle; TLR9, Toll-like receptor 9.
Compared with static delivery vehicles, dynamic DNA nanostructures offer another critical advantage: programming the availability of drugs. Gothelf and colleagues (36) designed a DNA origami box that opens or closes its lid only when specific external cues are recognized. With the lid open, the payload inside the box becomes available (Figure 11a) . Such dynamic structures present significantly advantages over static structures, which cannot control the availability of drug molecules.
This concept was implemented by Douglas et al. (6) , who designed an origami barrel capable of opening and closing in response to recognition of specific cues (Figure 11b) . When a box loaded with a cocktail of molecular agents is presented to cells, aptamer-encoded logic gate units on the barrel interact with receptors on the cells' surface, opening the lid and making the molecular payloads available for release. The authors confirmed the robustness of this approach with various cell lines, including Jurkat cells and human T lymphocyte cells. The reconfigurable DNA nanostructures may be further developed as delivery vehicles if novel release mechanisms such as external light irradiation are programmed. For example, two research groups led by Han (155) from DNA origami. Thus, it will become possible to design DNA nanorobots that can sense the environment, locate the target area, open up the structure, and release payloads.
CONCLUSIONS
Both static and dynamic DNA nanostructures have presented tremendous opportunities in biomedical research. These structures offer a set of properties that set them apart from conventional materials used in biomedical applications, including (a) precise controllability over nanostructures' physicochemical properties (e.g., size, shape, surface functionality); (b) programmability of sensing, computing, and responding to external stimuli (e.g., light, pH, biomarkers); (c) biological functionality (e.g., interaction with cellular proteins and genetic nucleic acids); and (d) biocompatibility and biodegradability. Although recent advances in DNA nanotechnology have demonstrated many exciting biomedical applications, the field is still in its infancy and is facing many challenges that hinder its translation to biomedical research. These challenges include but are not limited to the following:
1. Immunogenicity. Like many foreign materials, DNA nanostructures may trigger an unwanted immune response. Chemical modification of the bases and backbone could mitigate this issue. 2. Off-target gene regulation. DNA strands may contain certain sequences that nonspecifically regulate gene expressions by interacting with messenger RNAs, miRNAs, or genes. Rationally optimizing the sequence and chemically modifying the DNA may lower the risk of nonspecific gene regulations. 3. Pharmacokinetics and pharmacodynamics. The pharmacokinetic and pharmacodynamic profiles of DNA nanostructures are unclear. Both will be essential for in vivo applications of DNA nanostructures and require further investigation.
